Algernon Pharmaceuticals Inc.
Algernon Pharmaceuticals Inc. (AGN)
Communiqués de presse
Le 18 novembre/November 2021
Algernon Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every one hundred (100) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 1,678,809 common shares.
The name and symbol will not change.